Medicofarma Biotech SA (WSE:MDB)

Poland flag Poland · Delayed Price · Currency is PLN
0.486
-0.012 (-2.41%)
At close: Apr 27, 2026
89.11%
Market Cap 32.49M
Revenue (ttm) 119.90K
Net Income (ttm) -2.23M
Shares Out 67.98M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46,380
Average Volume 32,054
Open 0.500
Previous Close 0.498
Day's Range 0.446 - 0.505
52-Week Range 0.236 - 1.400
Beta 1.06
RSI 48.49
Earnings Date May 12, 2026

About Medicofarma Biotech

Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in Feb... [Read more]

Industry Biotechnology & Medical Research
Sector Healthcare
Founded 2001
Employees 14
Stock Exchange Warsaw Stock Exchange
Ticker Symbol MDB
Full Company Profile

Financial Performance

In 2025, Medicofarma Biotech's revenue was 119,900, a decrease of -90.21% compared to the previous year's 1.22 million. Losses were -2.23 million, -3.05% less than in 2024.

Financial Statements

News

There is no news available yet.